JAMP CALCIUM POLYSTYRENE SULFONATE
Google image searchProduct monograph
Active ingredient
calcium polystyrene sulfonate, 999 MG/G
DIN: 02502631
Dosage form(s): POWDER FOR SUSPENSION
Route(s) of administration: ORAL, RECTAL
Schedule: Ethical
Company: JAMP PHARMA CORPORATION
Date: 02-MAY-2022
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
- V03AE01 — POLYSTYRENE SULPHONATE (ATC/DDD)
Reference brand drug: Kayexalate
